Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay.

Authors :: Cobb WR
Bogden AE
Reich SD
Griffin TW
Kelton DE
LePage DJ
Source :: Cancer treatment reports [Cancer Treat Rep] 1983 Feb; Vol. 67 (2), pp. 173-8.
Publication Year :: 1983

Subjects :: Acenaphthenes
Animals
Dose-Response Relationship, Drug
Evaluation Studies as Topic
Harringtonines toxicity
Homoharringtonine
Humans
Kidney
Mice
Neoplasm Transplantation
Ribonucleotides toxicity
Alkaloids therapeutic use
Drug Evaluation, Preclinical methods
Harringtonines therapeutic use
Neoplasms drug therapy
Ribonucleotides therapeutic use

Tools